A new device for sorting and analyzing cells based on their electrical properties
A scalable electrokinetic flow cytometer and cell sorter
This study is testing a new device called ElectroFlow that sorts and analyzes cells by looking at their electrical properties, which could help doctors better understand different cell types and improve treatments for patients.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Aincobio LLC NIH-funded |
| Lab location | 1 site (Syracuse, UNITED STATES) |
| Project ID | NIH-10546934 on NIH RePORTER |
What this research studies
This research focuses on developing a novel electrokinetic flow cytometer called ElectroFlow, which can sort and analyze cells based on their electrical characteristics, such as deformability and charge. Unlike traditional methods that rely on size or specific markers, ElectroFlow utilizes dielectrophoresis and field-flow-fractionation to differentiate cells based on their unique cytoelectric properties. This innovative approach aims to enhance the precision of cell sorting and provide deeper insights into cellular functions and behaviors. Patients may benefit from improved diagnostic and therapeutic strategies that arise from better understanding of cell populations.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with conditions that involve heterogeneous cell populations, such as cancer or autoimmune diseases.
Not a fit: Patients with conditions that do not involve significant cellular heterogeneity or those who are not undergoing cell-based therapies may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate cell sorting techniques that improve diagnostics and treatment options for various diseases.
How similar studies have performed: While the approach of using electrical properties for cell sorting is innovative, similar technologies have shown promise in preliminary studies, indicating potential for success.
Where this research is happening
Syracuse, UNITED STATES
- Aincobio LLC — Syracuse, United States (Active)
Researchers
- Principal investigator: Damico, Lorenzo — Aincobio LLC
- Study coordinator: Damico, Lorenzo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.